Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Shock ; 52(3): 378-386, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-30239419

RESUMEN

INTRODUCTION: Prolonged low blood pressure <40 mmHg in hemorrhagic shock (HS) causes irreversible heart dysfunction, 'Shock Heart Syndrome' (SHS), which is associated with lethal arrhythmias (ventricular tachycardia or ventricular fibrillation [VT/VF]) leading to a poor prognosis. METHODS: To investigate whether the liposome-encapsulated human hemoglobin oxygen carrier (HbV) is comparable in effectiveness to autologous washed red blood cells (wRBCs) for improving arrhythmogenic properties in SHS, optical mapping analysis (OMP), electrophysiological study (EPS), and pathological examinations were performed in Sprague-Dawley rat hearts obtained from rats subjected to acute HS by withdrawing 30% of total blood volume. After acute HS, the rats were immediately resuscitated by transfusing exactly the same amount of saline (SAL), 5% albumin (5% ALB), HbV, or wRBCs. After excising the heart, OMP and EPS were performed in Langendorff-perfused hearts. RESULTS: OMP showed a tendency for abnormal conduction and significantly impaired action potential duration dispersion (APDd) in both ventricles with SAL and 5% ALB. In contrast, myocardial conduction and APDd were substantially preserved with HbV and wRBCs. Sustained VT/VF was easily provoked by a burst pacing stimulus to the left ventricle with SAL and 5% ALB. No VT/VF was induced with HbV and wRBCs. Pathology showed myocardial structural damage characterized by worse myocardial cell damage and Connexin43 with SAL and 5% ALB, whereas it was attenuated with HbV and wRBCs. CONCLUSIONS: Ventricular structural remodeling after HS causes VT/VF in the presence of APDd. Transfusion of HbV prevents VT/VF, similarly to transfusion of wRBCs, by preventing electrical remodeling and preserving myocardial structures in HS-induced SHS.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Sistema de Conducción Cardíaco , Hemoglobinas/farmacología , Miocardio , Choque Hemorrágico , Fibrilación Ventricular , Animales , Transfusión de Sangre Autóloga , Transfusión de Eritrocitos , Sistema de Conducción Cardíaco/metabolismo , Sistema de Conducción Cardíaco/fisiopatología , Masculino , Miocardio/metabolismo , Miocardio/patología , Ratas , Ratas Sprague-Dawley , Choque Hemorrágico/complicaciones , Choque Hemorrágico/fisiopatología , Choque Hemorrágico/terapia , Fibrilación Ventricular/etiología , Fibrilación Ventricular/patología , Fibrilación Ventricular/fisiopatología , Fibrilación Ventricular/terapia
2.
Biomed Res Int ; 2017: 3495021, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29094045

RESUMEN

Myocardial infarction (MI) patients are at high risk of potential lethal arrhythmia. Gap junction and microRNA-1 (miR-1) are both arrhythmia generating conditions. The present study investigated whether Wenxin Granules (Wenxin-Keli, WXKL) could prevent potential lethal arrhythmia by improving gap junctions and miR-1 following MI. Male Sprague-Dawley rats were divided randomly into control, model, metoprolol, low dose WXKL, and high dose WXKL groups. The MI rat model was created by coronary artery ligation. Treatments were administrated intragastrically to the rats for 4 weeks. Conventional transmission electron microscopy was performed to observe the ultrastructure of gap junctions. Quantitative real-time PCR and western blotting were used to detect the expression of miR-1, protein kinase C (PKC), and related proteins. Additionally, a programmatic electrophysiological stimulation test was performed to detect the ventricular fibrillation threshold (VFT). WXKL protected the ultrastructure of the gap junctions and their constituent Cx43 by regulating miR-1 and PKC mediated signal transduction and increased the VFT significantly in the rat MI model. The results suggested that WXKL is an effective alternative medicine to prevent potentially lethal arrhythmia following MI.


Asunto(s)
Arritmias Cardíacas/tratamiento farmacológico , Conexina 43/genética , Medicamentos Herbarios Chinos/administración & dosificación , MicroARNs/genética , Infarto del Miocardio/tratamiento farmacológico , Fibrilación Ventricular/tratamiento farmacológico , Animales , Arritmias Cardíacas/genética , Arritmias Cardíacas/patología , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/fisiopatología , Modelos Animales de Enfermedad , Uniones Comunicantes/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Infarto del Miocardio/genética , Infarto del Miocardio/patología , Miocardio/patología , Proteína Quinasa C/genética , Ratas , Fibrilación Ventricular/genética , Fibrilación Ventricular/patología
3.
Circ Arrhythm Electrophysiol ; 8(6): 1498-506, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26359480

RESUMEN

BACKGROUND: Ventricular tachycardia recurrence can occur after ventricular tachycardia ablation because of incomplete and nontransmural ventricular lesion formation. We sought to compare the lesions made by a novel irrigated needle catheter to conventional radiofrequency lesions. METHODS AND RESULTS: Thirteen female sheep (4.6±0.7 years, 54±8 kg) were studied. In 7 sheep, 60-s radiofrequency applications were performed using an irrigated needle catheter. In 6 sheep, conventional lesions were made using a 4-mm irrigated catheter. 1.5T in vivo and high-density magnetic resonance imaging (9.4T) were performed on explanted hearts from animals receiving needle radiofrequency. Conventional lesion volume was calculated as (1/6)×π×(A×B(2)+C×D(2)/2). Needle lesion volume was measured as Σ(π×r(2))/2 with a slice thickness of 1 mm. The dimensions of all lesions were also measured on gross pathology. Additional histological analysis of the needle lesions was performed. One hundred twenty endocardial left ventricular ablation lesions (conventional, n=60; needle, n=60) were created. At necropsy, more lesions were found using needle versus conventional radiofrequency (90% versus 75%; P<0.05). Comparing needle versus conventional radiofrequency: lesion volume was larger (1030±362 versus 488±384 mm(3); P<0.001), lesion depth was increased (9.9±2.7 versus 5±2.4 mm; P<0.001), and more transmural lesions were created (62.5% versus 17%; P<0.01). Pericardial contrast injection was observed in 4 apical attempts using needle radiofrequency, however, with no adverse effects. Steam pops occurred in 3 attempts using conventional radiofrequency. CONCLUSIONS: Irrigated needle ablation is associated with more frequent, larger, deeper, and more often transmural lesions compared with conventional irrigated ablation. This technology might be of value to treat intramural or epicardial ventricular tachycardia substrates resistant to conventional ablation.


Asunto(s)
Ablación por Catéter/métodos , Ventrículos Cardíacos/cirugía , Taquicardia Ventricular/cirugía , Irrigación Terapéutica/métodos , Fibrilación Ventricular/cirugía , Animales , Biopsia , Catéteres Cardíacos , Estimulación Cardíaca Artificial , Ablación por Catéter/efectos adversos , Ablación por Catéter/instrumentación , Modelos Animales de Enfermedad , Técnicas Electrofisiológicas Cardíacas , Diseño de Equipo , Femenino , Ventrículos Cardíacos/patología , Ventrículos Cardíacos/fisiopatología , Imagen por Resonancia Magnética , Agujas , Ovinos , Taquicardia Ventricular/patología , Taquicardia Ventricular/fisiopatología , Irrigación Terapéutica/efectos adversos , Irrigación Terapéutica/instrumentación , Fibrilación Ventricular/patología , Fibrilación Ventricular/fisiopatología
4.
J Cardiovasc Pharmacol ; 64(2): 127-33, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24662492

RESUMEN

OBJECTIVES: To investigate the effects and mechanisms of Nardostachys chinensis (NC) on spontaneous ventricular arrhythmias in rats with hyper-acute myocardial infarction (AMI). METHODS: Seventy-two rats were randomly divided into the control group (n = 24), metoprolol group (n = 24), and the NC group (n = 24). Premature ventricular contractions (PVCs), ventricular tachycardias (VTs), ventricular fibrillations (VFs), and blood pressure were monitored for 4 hours after coronary artery ligation. The connexin 43 (Cx43) expression in ventricular myocardium was measured by immunohistochemistry, Western blot, and real-time RT-PCR. RESULTS: Compared with the control, metoprolol and NC decreased the VF incidence (50% vs. 4.2%, P < 0.001, and 50% vs. 12.5%, P = 0.005, respectively). There was a steady decrease in the cumulative number of PVCs and VTs within 4 hours from ligating in 3 groups. Compared with the control, metoprolol and NC reduced the cumulative number of VTs and PVCs. Compared with control, metoprolol and NC decreased the infarct size of the left ventricular tissue (55.98% ± 6.20% vs. 39.13% ± 4.53%, P < 0.001, and 55.98% ± 6.20% vs. 42.39% ± 3.44%, P < 0.001, respectively). The results from immunohistochemistry, Western blot, and real-time RT-PCR showed that the protein expression of Cx43 in the control group was significantly lower than that in the metoprolol and NC groups in the infarcted zone. CONCLUSIONS: NC decreased the incidence of spontaneous ventricular arrhythmias (especially VF), reduced Cx43 degradation, and improved Cx43 redistribution in myocardial infarcted zone in rats with hyper-AMI. The data of the present study indicated that NC may be a promising drug in the future to prevent patients with AMI from lethal ventricular arrhythmias in prehospital setting.


Asunto(s)
Antiarrítmicos/uso terapéutico , Medicamentos Herbarios Chinos/uso terapéutico , Infarto del Miocardio/tratamiento farmacológico , Nardostachys/química , Taquicardia Ventricular/prevención & control , Fibrilación Ventricular/prevención & control , Complejos Prematuros Ventriculares/prevención & control , Animales , Antiarrítmicos/administración & dosificación , Presión Sanguínea/efectos de los fármacos , Western Blotting , Conexina 43/metabolismo , Medicamentos Herbarios Chinos/administración & dosificación , Electrocardiografía , Femenino , Inmunohistoquímica , Masculino , Metoprolol/administración & dosificación , Metoprolol/uso terapéutico , Infarto del Miocardio/complicaciones , Infarto del Miocardio/metabolismo , Infarto del Miocardio/patología , Ratas Sprague-Dawley , Reacción en Cadena en Tiempo Real de la Polimerasa , Rizoma/química , Taquicardia Ventricular/etiología , Taquicardia Ventricular/metabolismo , Taquicardia Ventricular/patología , Fibrilación Ventricular/etiología , Fibrilación Ventricular/metabolismo , Fibrilación Ventricular/patología , Complejos Prematuros Ventriculares/etiología , Complejos Prematuros Ventriculares/metabolismo , Complejos Prematuros Ventriculares/patología
5.
Circ Arrhythm Electrophysiol ; 6(6): 1192-9, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24243784

RESUMEN

BACKGROUND: Previous studies showed that endocardial activation during long-duration ventricular fibrillation (VF) exhibits organized activity. We identified and quantified the different types of organized activity. METHODS AND RESULTS: Two 64-electrode basket catheters were inserted, respectively, into the left ventricle and right ventricle of dogs to record endocardial activation from the endocardium during 7 minutes of VF (controls, n=6). The study was repeated with the K(ATP) channel opener pinacidil (n=6) and the calcium channel blocker flunarizine (n=6). After 2 minutes of VF without drugs, 2 highly organized left ventricular endocardial activation patterns were observed: (1) ventricular electric synchrony pattern, in which endocardial activation arose focally and either had a propagation sequence similar to sinus rhythm or arose near papillary muscles, and (2) stable pattern, in which activation was regular and repeatable, sometimes forming a stable re-entrant circuit around the left ventricular apex. Between 3 and 7 minutes of VF, the percent of time ventricular electric synchrony was present was control=25%, flunarizine=24% (P=0.44), and pinacidil=0.1% (P<0.001) and the percent of time stable pattern was present was control=71%, flunarizine=48% (P<0.001), and pinacidil=56% (P<0.001). The remainder of the time, nonstable re-entrant activation with little repeatability was present. CONCLUSIONS: After 3 minutes, VF exhibits 2 highly organized endocardial activation patterns 96% of the time, one potentially arising focally in the Purkinje system that was prevented with a K(ATP) channel opener but not a calcium channel blocker and the other potentially arising from a stable re-entrant circuit near the apical left ventricular endocardium.


Asunto(s)
Sistema de Conducción Cardíaco/fisiopatología , Ramos Subendocárdicos/fisiología , Fibrilación Ventricular/fisiopatología , Animales , Bloqueadores de los Canales de Calcio/farmacología , Muerte Súbita Cardíaca , Perros , Técnicas Electrofisiológicas Cardíacas , Endocardio/fisiopatología , Femenino , Flunarizina/farmacología , Sistema de Conducción Cardíaco/efectos de los fármacos , Canales KATP/efectos de los fármacos , Masculino , Pinacidilo/farmacología , Fibrilación Ventricular/patología
6.
Curr Opin Cardiol ; 27(4): 412-9, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22565141

RESUMEN

PURPOSE OF REVIEW: To provide an overview of the key earlier intervention studies with marine omega-3 fatty acids and to review and comment on recent studies reporting on mortality outcomes and on selected underlying mechanisms of action. RECENT FINDINGS: Studies relating marine omega-3 fatty acid status to current or future outcomes continue to indicate benefits, for example, on incident heart failure, congestive heart failure, acute coronary syndrome, and all-cause mortality. New mechanistic insights into the actions of marine omega-3 fatty acids have been gained. Three fairly large secondary prevention trials have not confirmed the previously reported benefit of marine omega-3 fatty acids towards mortality in survivors of myocardial infarction. Studies of marine omega-3 fatty acids in atrial fibrillation and in cardiac surgery-induced atrial fibrillation have produced inconsistent findings and meta-analyses demonstrate no benefit. A study confirmed that marine omega-3 fatty acids reduce the inflammatory burden with advanced atherosclerotic plaques, so inducing greater stability. SUMMARY: Recent studies of marine omega-3 fatty acids on morbidity of, and mortality from, coronary and cardiovascular disease have produced mixed findings. These studies raise new issues to be addressed in future research.


Asunto(s)
Enfermedad de la Arteria Coronaria/tratamiento farmacológico , Ácidos Docosahexaenoicos/uso terapéutico , Ácido Eicosapentaenoico/uso terapéutico , Inflamación/tratamiento farmacológico , Fibrilación Atrial/patología , Fibrilación Atrial/prevención & control , Coagulación Sanguínea , Plaquetas , Enfermedad de la Arteria Coronaria/mortalidad , Enfermedad de la Arteria Coronaria/patología , Fibrinólisis/efectos de los fármacos , Humanos , Inflamación/patología , Prevención Secundaria/métodos , Estados Unidos , Fibrilación Ventricular/patología , Fibrilación Ventricular/prevención & control
8.
Heart Rhythm ; 7(6): 763-8, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20156592

RESUMEN

BACKGROUND: Better risk stratification of patients receiving an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is needed. Although microvolt T-wave alternans (MTWA) and electrophysiologic study (EPS) are independent markers for SCD, the Alternans Before Cardioverter Defibrillator (ABCD) trial found the combination to be more predictive than either test alone. OBJECTIVE: The purpose of this study was to test the hypothesis that EPS and MTWA measure different elements of the arrhythmogenic substrate and, therefore, predict distinct arrhythmia outcomes. METHODS: The ABCD trial enrolled 566 patients with ischemic cardiomyopathy, left ventricular ejection fraction (LVEF) 0.30. CONCLUSION: The study data suggest that EPS and MTWA identify distinct arrhythmogenic substrates and, when used in combination, may better predict the complex electroanatomic substrates that underlie the risk for SCD.


Asunto(s)
Muerte Súbita Cardíaca/prevención & control , Técnicas Electrofisiológicas Cardíacas , Taquicardia Ventricular/terapia , Fibrilación Ventricular/terapia , Anciano , Biomarcadores , Muerte Súbita Cardíaca/epidemiología , Muerte Súbita Cardíaca/etiología , Electrofisiología , Femenino , Humanos , Israel/epidemiología , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Pronóstico , Medición de Riesgo , Factores de Riesgo , Volumen Sistólico , Taquicardia Ventricular/complicaciones , Taquicardia Ventricular/patología , Fibrilación Ventricular/complicaciones , Fibrilación Ventricular/patología , Función Ventricular Izquierda
9.
Am J Physiol Heart Circ Physiol ; 291(3): H1329-36, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16617126

RESUMEN

The effects of kernel extract obtained from sour cherry (Prunus cerasus) seed on the postischemic cardiac recovery were studied in isolated working rat hearts. Rats were treated with various daily doses of the extract for 14 days, and hearts were then isolated and subjected to 30 min of global ischemia followed by 120 min of reperfusion. The incidence of ventricular fibrillation (VF) and tachycardia (VT) fell from their control values of 92% and 100% to 50% (not significant) and 58% (not significant), 17% (P<0.05), and 25% (P<0.05) with the doses of 10 mg/kg and 30 mg/kg of the extract, respectively. Lower concentrations of the extract (1 and 5 mg/kg) failed to significantly reduce the incidence of VF and VT during reperfusion. Sour cherry seed kernel extract (10 and 30 mg/kg) significantly improved the postischemic recovery of cardiac function (coronary flow, aortic flow, and left ventricular developed pressure) during reperfusion. We have also demonstrated that the extract-induced protection in cardiac function significantly reflected in a reduction of infarct size. Immunohistochemistry indicates that a reduction in caspase-3 activity and apoptotic cells by the extract, beside other potential action mechanisms of proanthocyanidin, trans-resveratrol, and flavonoid components of the extract, could be responsible for the cardioprotection in ischemic-reperfused myocardium.


Asunto(s)
Miocardio/patología , Fitoterapia , Prunus , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/prevención & control , Semillas , Animales , Apoptosis , Caspasa 3 , Caspasas/metabolismo , Relación Dosis-Respuesta a Droga , Incidencia , Masculino , Infarto del Miocardio/patología , Miocardio/metabolismo , Extractos Vegetales/uso terapéutico , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/patología , Taquicardia/tratamiento farmacológico , Taquicardia/patología , Taquicardia/prevención & control , Fibrilación Ventricular/tratamiento farmacológico , Fibrilación Ventricular/patología , Fibrilación Ventricular/prevención & control
10.
Cardiovasc Drugs Ther ; 19(1): 33-40, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15883754

RESUMEN

Although recent studies suggest that erythropoietin (EPO) may reduce multiple features of the myocardial ischemia/reperfusion injury, the cellular mechanisms and the clinical implications of EPO-induced cardioprotection are still unclear. Thus, in this study, we clarified dose-dependent effects of EPO administered just before reperfusion on infarct size and the incidence of ventricular fibrillation and evaluated the involvement of the phosphatidylinositol-3 (PI3) kinase in the in vivo canine model. The canine left anterior descending coronary artery was occluded for 90 min followed by 6 h of reperfusion. A single intravenous administration of EPO just before reperfusion significantly reduced infarct size (high dose (1,000 IU/kg): 7.7 +/- 1.6%, low dose (100 IU/kg): 22.1 +/- 2.4%, control: 40.0 +/- 3.6%) in a dose-dependent manner. Furthermore, the high, but not low, dose of EPO administered as a single injection significantly reduced the incidence of ventricular fibrillation during reperfusion (high dose: 0%, low dose: 40.0%, control: 50.0%). An intracoronary administration of a PI3 kinase inhibitor, wortmannin, blunted the infarct size-limiting and anti-arrhythmic effects of EPO. Low and high doses of EPO equally induced Akt phosphorylation and decreased the equivalent number of TUNEL-positive cells in the ischemic myocardium of dogs. These effects of EPO were abolished by the treatment with wortmannin. In conclusion, EPO administered just before reperfusion reduced infarct size and the incidence of ventricular fibrillation via the PI3 kinase-dependent pathway in canine hearts. EPO administration can be a realistic strategy for the treatment of acute myocardial infarction.


Asunto(s)
Cardiotónicos/uso terapéutico , Eritropoyetina/uso terapéutico , Infarto del Miocardio/prevención & control , Reperfusión Miocárdica , Fosfatidilinositol 3-Quinasas/metabolismo , Fibrilación Ventricular/prevención & control , Animales , Apoptosis/efectos de los fármacos , Recuento de Células Sanguíneas , Cardiotónicos/administración & dosificación , Circulación Coronaria/efectos de los fármacos , Modelos Animales de Enfermedad , Perros , Relación Dosis-Respuesta a Droga , Eritropoyetina/administración & dosificación , Humanos , Etiquetado Corte-Fin in Situ , Infarto del Miocardio/enzimología , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Reperfusión Miocárdica/efectos adversos , Fosforilación , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-akt , Proteínas Recombinantes , Fibrilación Ventricular/enzimología , Fibrilación Ventricular/patología , Fibrilación Ventricular/fisiopatología
11.
Am J Physiol Heart Circ Physiol ; 288(4): H1997-2005, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15539424

RESUMEN

Angiotensin receptor blockers (ARBs) reduce adverse left ventricular (LV) remodeling and improve LV function and survival when started postmyocardial infarction (MI). ARBs also reduce ventricular arrhythmias during ischemia-reperfusion injury when started pre-MI. No information exists regarding their efficacy and safety when started pre-MI and continued peri- and post-MI. We evaluated whether the ARB losartan improves the outcome when started pre-MI and continued peri- and post-MI. Male Wistar rats (n = 502) were treated for 7 days pre-MI with losartan at a high dose (30 mg.kg(-1).day(-1)), progressively increasing dose (3 mg.kg(-1).day(-1) increased to 10 mg.kg(-1).day(-1) 10 days and 30 mg.kg(-1).day(-1) 20 days post-MI), or no treatment. Ambulatory systolic blood pressure and Holter monitoring were performed for 24 h post-MI. Echocardiography was done 30 days post-MI, and LV remodeling, cardiac hemodynamics, and fetal gene expression were assessed 38 days post-MI. High-dose losartan reduced 24-h post-MI survival compared with the progressive dose and control (21.9% vs. 36.6% and 38.1%, P = 0.033 and P = 0.009, respectively). This was associated with greater hypotension in the high dose and no change in ventricular arrhythmias in all groups. In 24-h post-MI survivors, the progressive dose group had reduced mortality from 24 h to 38 days (8.5% vs. 28.6% for control vs. 38.9% for high dose, P = 0.032 and P = 0.01, respectively). Survivors of both losartan groups demonstrated improved LV remodeling, cardiac hemodynamics, preserved GLUT-4, and reduced cardiac fetal gene expression. Pretreatment with ARBs does not reduce 24-h post-MI ventricular arrhythmias or survival, and high doses increase mortality by causing excessive hypotension. In 24-h post-MI survivors, progressively increasing doses of losartan have multiple beneficial effects, including improved survival.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Losartán/farmacología , Infarto del Miocardio/tratamiento farmacológico , Taquicardia Ventricular/tratamiento farmacológico , Fibrilación Ventricular/tratamiento farmacológico , Remodelación Ventricular/efectos de los fármacos , Actinas/genética , Animales , Factor Natriurético Atrial/genética , Presión Sanguínea , Monitoreo Ambulatorio de la Presión Arterial , Volumen Cardíaco , Relación Dosis-Respuesta a Droga , Ecocardiografía , Transportador de Glucosa de Tipo 4 , Incidencia , Masculino , Proteínas de Transporte de Monosacáridos/genética , Proteínas Musculares/genética , Infarto del Miocardio/mortalidad , Infarto del Miocardio/patología , Cadenas Pesadas de Miosina/genética , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisis , Ratas , Ratas Wistar , Taquicardia Ventricular/mortalidad , Taquicardia Ventricular/patología , Fibrilación Ventricular/mortalidad , Fibrilación Ventricular/patología , Presión Ventricular
12.
Circ Res ; 89(12): 1216-23, 2001 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-11739288

RESUMEN

Ventricular fibrillation (VF) is the leading cause of sudden cardiac death. Yet, the mechanisms of VF remain elusive. Pixel-by-pixel spectral analysis of optical signals was carried out in video imaging experiments using a potentiometric dye in the Langendorff-perfused guinea pig heart. Dominant frequencies (peak with maximal power) were distributed throughout the ventricles in clearly demarcated domains. The fastest domain (25 to 32 Hz) was always on the anterior left ventricular (LV) wall and was shown to result from persistent rotor activity. Intermittent block and breakage of wavefronts at specific locations in the periphery of such rotors were responsible for the domain organization. Patch-clamping of ventricular myocytes from the LV and the right ventricle (RV) demonstrated an LV-to-RV drop in the amplitude of the outward component of the background rectifier current (I(B)). Computer simulations suggested that rotor stability in LV resulted from relatively small rectification of I(B) (presumably I(K1)), whereas instability, termination, and wavebreaks in RV were a consequence of strong rectification. This study provides new evidence in the isolated guinea pig heart that a persistent high-frequency rotor in the LV maintains VF, and that spatially distributed gradients in I(K1) density represent a robust ionic mechanism for rotor stabilization and wavefront fragmentation.


Asunto(s)
Sistema de Conducción Cardíaco/fisiopatología , Ventrículos Cardíacos/fisiopatología , Canales de Potasio de Rectificación Interna/metabolismo , Potasio/metabolismo , Fibrilación Ventricular/fisiopatología , Animales , Mapeo del Potencial de Superficie Corporal , Simulación por Computador , Electrocardiografía , Técnicas Electrofisiológicas Cardíacas , Cobayas , Ventrículos Cardíacos/patología , Técnicas In Vitro , Modelos Cardiovasculares , Técnicas de Placa-Clamp , Fibrilación Ventricular/etiología , Fibrilación Ventricular/patología
13.
Middle East J Anaesthesiol ; 16(1): 67-79, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11281049

RESUMEN

In this study, we aimed to compare the myocardial protective effects of high dose ascorbic acid with the effects obtained by adding diltiazem to high dose ascorbic acid. We studied 30 elective cardiac surgery patients prospectively. In ascorbic acid group (group AA), ascorbic acid was given after induction and just before aortic declamping, 50 mg.kg-1 each time. In ascorbic acid + diltiazem group (group AA + D), diltiazem was added to ascorbic acid (0.3 mg.kg-1, i.v. after induction and then 2 micrograms.kg-1 min-1 i.v. infusion until declamping). Group C was the control group. There was no significant difference between groups in terms of cardiac enzyme levels. After declamping, the arterial and coronary sinus malondialdehyde levels, measured as a marker of lipid peroxidation, were increased significantly in the group C while remained stable in the other two groups. Ventricular fibrillation (VF) after declamping was positive in 3, 1 and 6 patients in the groups AA, AA + D and C respectively. In this study, we observed the prevention of lipid peroxidation in the group AA and group AA + D. The only positive result obtained by addition of diltiazem to high dose ascorbic acid was the decrease in the frequency of VF after declamping. We concluded that the prevention of lipid peroxidation in the groups AA and AA + D provided no measurable protection over myocardial ischaemia-reperfusion injury.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Bloqueadores de los Canales de Calcio/uso terapéutico , Diltiazem/uso terapéutico , Daño por Reperfusión Miocárdica/prevención & control , Adulto , Anciano , Ácido Ascórbico/sangre , Puente de Arteria Coronaria , Femenino , Hemodinámica/fisiología , Humanos , Peroxidación de Lípido/fisiología , Masculino , Malondialdehído/metabolismo , Persona de Mediana Edad , Daño por Reperfusión Miocárdica/patología , Miocardio/enzimología , Miocardio/patología , Complicaciones Posoperatorias/patología , Complicaciones Posoperatorias/prevención & control , Estudios Prospectivos , Fibrilación Ventricular/patología
14.
J Cardiovasc Electrophysiol ; 11(12): 1364-71, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11196560

RESUMEN

INTRODUCTION: The mechanisms that maintain ventricular fibrillation (VF) are not completely understood. It has been proposed that increased ventricular wall thickness destabilizes VF wavefronts and therefore is an important determinant of VF activation patterns. We hypothesized that if this is the case, then VF patterns on the thin-walled right ventricle (RV) should be simpler than those on the thick-walled left ventricle (LV). METHODS AND RESULTS: In seven open chest pigs, we mapped VF simultaneously from two epicardial recording arrays, one on the RV and one on the LV. Each array contained 504 unipolar electrodes (in a 21 x 24 grid) spaced by 2 mm. We used specialized pattern analysis methods to compute quantitative descriptors of RV and LV activation patterns. Our data show that VF is more organized in the RV than the LV, containing fewer, larger wavefronts that follow fewer distinct pathways and are less likely to fragment or collide with other wavefronts. The incidence, size, and cycle length of reentrant circuits were similar in the two ventricles, but RV reentry persisted for more cycles. These results are not predicted by the differences in electrophysiologic properties between LV and RV that have been reported in mammalian hearts. CONCLUSION: The geometry of the ventricular wall, particularly wall thickness, is an important determinant of VF activation patterns.


Asunto(s)
Disfunción Ventricular Izquierda/fisiopatología , Disfunción Ventricular Derecha/fisiopatología , Fibrilación Ventricular/fisiopatología , Potenciales de Acción , Animales , Electrocardiografía , Electrodos Implantados , Técnicas Electrofisiológicas Cardíacas , Sistema de Conducción Cardíaco/fisiopatología , Ventrículos Cardíacos/patología , Miocardio/patología , Pericardio/fisiopatología , Procesamiento de Señales Asistido por Computador , Porcinos , Disfunción Ventricular Izquierda/complicaciones , Disfunción Ventricular Izquierda/patología , Disfunción Ventricular Derecha/complicaciones , Disfunción Ventricular Derecha/patología , Fibrilación Ventricular/complicaciones , Fibrilación Ventricular/patología
15.
Neurosci Behav Physiol ; 25(3): 257-65, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7477828

RESUMEN

It has been demonstrated in chronic experiments on animals (rabbits, rats) that in the presence of a predominance of sympathetic influences on the heart during emotional stress, the disturbances that appear in metabolism and myocardial ultrastructure promote a decrease in the electrical stability of the heart, the development of disturbances in cardiac rhythm, and arterial hypertension. A predominance of parasympathetic influences on the heart during stress, to the contrary, leads to an increase in the electrical stability of the heart, and also impedes an increase in the content of catecholamines and the development of structural injuries in the myocardium. At the same time, arterial hypertension is absent. An inference is drawn regarding the adaptive-trophic, protective action of the vagus nerves on the heart during emotional stress.


Asunto(s)
Corazón/fisiopatología , Estrés Psicológico/fisiopatología , Fibrilación Ventricular/fisiopatología , Animales , Arritmias Cardíacas/fisiopatología , Catecolaminas/metabolismo , Estimulación Eléctrica , Electrocardiografía , Electrofisiología , Corazón/inervación , Hipertensión/fisiopatología , Hipotálamo/fisiología , Inmovilización , Miocardio/metabolismo , Miocardio/patología , Sistema Nervioso Parasimpático/citología , Sistema Nervioso Parasimpático/fisiología , Conejos , Ratas , Ratas Wistar , Estrés Psicológico/metabolismo , Estrés Psicológico/patología , Sistema Nervioso Simpático/citología , Sistema Nervioso Simpático/fisiología , Nervio Vago/fisiología , Fibrilación Ventricular/patología
16.
Ann Emerg Med ; 22(9): 1385-91, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8363112

RESUMEN

STUDY OBJECTIVE: To evaluate the effects of standard-dose versus high-dose epinephrine on myocardial high-energy phosphate metabolism during resuscitation from cardiac arrest. DESIGN: Prospective, nonrandomized, controlled study using a swine model of cardiac arrest and resuscitation. INTERVENTIONS: After anesthesia, intravascular pressure instrumentation, and ten minutes of ventricular fibrillation arrest, closed-chest CPR was begun. After three minutes of CPR, animals were allocated to receive either 0.02 mg/kg i.v. standard-dose epinephrine (eight) or 0.2 mg/kg i.v. high-dose epinephrine (nine). The animals underwent thoracotomy and rapid-freezing transmural myocardial core biopsy for high-energy phosphate analysis 3.5 minutes after epinephrine administration. High-energy phosphate values were blindly determined using high-pressure liquid chromatography. RESULTS: Intravascular pressure (mm Hg) and high-energy phosphate (nmol/mg protein) results for standard-dose epinephrine versus high-dose epinephrine are, respectively, coronary perfusion pressure, 15.3 +/- 7.8 versus 23.7 +/- 5.5 (P = .0009); phosphocreatine, 0.4 +/- 0.8 versus 6.2 +/- 4.4 (P = .0003); adenosine triphosphate, 9.8 +/- 4.8 versus 12.7 +/- 5.7 (P = .30); adenosine diphosphate, 5.4 +/- 2.1 versus 6.1 +/- 1.3 (P = .41); and adenylate charge, 0.68 +/- 0.12 versus 0.72 +/- 0.12 (P = .87). CONCLUSION: High-dose epinephrine does not deplete myocardial high-energy phosphate when given in this model of prolonged ventricular fibrillation. High-dose epinephrine increases coronary perfusion pressure compared with standard-dose epinephrine. High-dose epinephrine administration repletes phosphocreatine during closed-chest CPR, thereby increasing myocardial energy stores.


Asunto(s)
Adenosina Difosfato/análisis , Adenosina Trifosfato/análisis , Reanimación Cardiopulmonar/métodos , Epinefrina/farmacología , Paro Cardíaco/tratamiento farmacológico , Hemodinámica/efectos de los fármacos , Miocardio/química , Miocardio/metabolismo , Fosfocreatina/análisis , Porcinos , Fibrilación Ventricular/tratamiento farmacológico , Adenosina/análisis , Adenosina Monofosfato/análisis , Animales , Biopsia , Análisis de los Gases de la Sangre , Cromatografía Líquida de Alta Presión , Protocolos Clínicos , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Epinefrina/administración & dosificación , Guanosina Trifosfato/análisis , Paro Cardíaco/metabolismo , Paro Cardíaco/patología , Paro Cardíaco/fisiopatología , Inyecciones Intravenosas , Inosina/análisis , Inosina Monofosfato/análisis , Miocardio/patología , Fibrilación Ventricular/metabolismo , Fibrilación Ventricular/patología , Fibrilación Ventricular/fisiopatología
17.
Biull Eksp Biol Med ; 113(4): 431-3, 1992 Apr.
Artículo en Ruso | MEDLINE | ID: mdl-1391911

RESUMEN

The balance of catecholamines (CA) and their metabolites in the canine heart during myocardial fibrillation and 1, 2, 3, 4, 5, 6 hours after death was studied. The fibrillation was caused by low myocardial electrostimulation. The comparative neuro-morphometric analysis of the CA-containing structures in 1 and 5 min of the fibrillation and the determination of the norepinephrine, its precursors and metabolites by HPLC-ED method was done. There was an increase of the myocardial norepinephrine (20%), 3-4-dihydroxyphenylethyleneglycol (25%) and decrease of the dopamine (50%) contents without any qualitative changes of CA metabolism. Autolysis leads to the successive decrease of the norepinephrine and dopamine contents without any qualitative changes of the CA metabolism too. These data suggest that autopsies could be used for the determination of the myocardial CA content and the qualitative characteristics of the CA metabolism before death in those who died suddenly.


Asunto(s)
Autólisis , Catecolaminas/metabolismo , Miocardio/metabolismo , Fibrilación Ventricular/metabolismo , Animales , Autopsia , Cromatografía Líquida de Alta Presión , Muerte Súbita/patología , Perros , Dopamina/metabolismo , Miocardio/patología , Norepinefrina/metabolismo , Factores de Tiempo , Fibrilación Ventricular/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA